# Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study.

> **NCT02582424** · NA · COMPLETED · sponsor: **Primus Pharmaceuticals** · enrollment: 103 (actual)

## Conditions studied

- Hyperlipidemia

## Interventions

- **OTHER:** PD-L0101
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02582424
- **Lead sponsor:** Primus Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-08
- **Final completion:** 2013-09
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2016-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02582424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02582424, "Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study.". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02582424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*